Better Glycemic Control With Closed-Loop Insulin Delivery

Share this content:
Better Glycemic Control With Closed-Loop Insulin Delivery
Better Glycemic Control With Closed-Loop Insulin Delivery

WEDNESDAY, Oct. 3, 2018 (HealthDay News) -- For patients with suboptimally controlled type 1 diabetes, day-and-night hybrid closed-loop insulin delivery improves glucose control compared with sensor-augmented pump therapy, according to a study published online Oct. 3 in The Lancet. The research was published to coincide with the annual meeting of the European Association for the Study of Diabetes, held from Oct. 1 to 5 in Berlin.

Martin Tauschmann, M.D., from the University of Cambridge in the United Kingdom, and colleagues randomly assigned participants aged 6 years and older treated with an insulin pump and with suboptimal glycemic control to receive hybrid closed-loop therapy (46 patients) or sensor-augmented pump therapy (40 patients) during 12 weeks of free living.

The researchers found that glucose was within the target range of more than 3.9 mmol/L and less than 10.0 mmol/L for a significantly greater proportion of time in the closed-loop group (65 versus 54 percent) compared with the control group. Hemoglobin A1c (HbA1c) values reduced from a screening value of 8.3 percent to 8.0 percent after the four-week run-in and to 7.4 percent after the 12-week intervention period in the closed-loop group. In the control group, the corresponding HbA1c values were 8.2, 7.8, and 7.7 percent. There was a significantly greater reduction in HbA1c percentages in the closed-loop group (mean difference in change, 0.36 percent).

"Hybrid closed-loop insulin delivery improves glucose control while reducing the risk of hypoglycemia across a wide age range in patients with suboptimally controlled type 1 diabetes," the authors write.

Several authors disclosed financial ties to the pharmaceutical and medical device industries.

Abstract/Full Text
Editorial
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »